Garnet L Anderson

Summary

Affiliation: Fred Hutchinson Cancer Research Center
Country: USA

Publications

  1. pmc Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause
    Ross L Prentice
    Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
    Am J Epidemiol 170:12-23. 2009
  2. pmc Investigation of gene-by-sex interactions for lipid traits in diverse populations from the population architecture using genomics and epidemiology study
    Kira C Taylor
    Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    BMC Genet 14:33. 2013
  3. pmc Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial
    Garnet L Anderson
    Fred Hutchinson Cancer Research Center, Public Health Sciences, Seattle, WA 98109, USA
    Lancet Oncol 13:476-86. 2012
  4. doi request reprint Obesity and the risk for premenopausal and postmenopausal breast cancer
    Garnet L Anderson
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, PO Box 19024, Seattle, WA 98109, USA
    Cancer Prev Res (Phila) 5:515-21. 2012
  5. ncbi request reprint Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin
    Garnet L Anderson
    WHI Clinical Coordinating Center, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N, M3 A410, P O Box 19024, Seattle, WA 98109 1024, United States
    Maturitas 55:103-15. 2006
  6. pmc Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study
    Garnet L Anderson
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, PO Box 19024, M3 A410, Seattle, WA 98109 1024, USA
    J Natl Cancer Inst 102:26-38. 2010
  7. ncbi request reprint Monitoring and reporting of the Women's Health Initiative randomized hormone therapy trials
    Garnet L Anderson
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    Clin Trials 4:207-17. 2007
  8. ncbi request reprint Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial
    Garnet L Anderson
    Fred Hutchinson Cancer Research Center, Seattle, Wash 98109 1024, USA
    JAMA 291:1701-12. 2004
  9. ncbi request reprint Implementation of the Women's Health Initiative study design
    Garnet L Anderson
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Ann Epidemiol 13:S5-17. 2003
  10. ncbi request reprint Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial
    Garnet L Anderson
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Wash 98109, USA
    JAMA 290:1739-48. 2003

Detail Information

Publications50

  1. pmc Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause
    Ross L Prentice
    Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
    Am J Epidemiol 170:12-23. 2009
    ....
  2. pmc Investigation of gene-by-sex interactions for lipid traits in diverse populations from the population architecture using genomics and epidemiology study
    Kira C Taylor
    Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    BMC Genet 14:33. 2013
    ..Here, we investigated whether GWAS-identified SNPs for lipid traits exhibited heterogeneity by sex in the Population Architecture using Genomics and Epidemiology (PAGE) study...
  3. pmc Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial
    Garnet L Anderson
    Fred Hutchinson Cancer Research Center, Public Health Sciences, Seattle, WA 98109, USA
    Lancet Oncol 13:476-86. 2012
    ..We aimed to assess the influence of oestrogen use on longer term breast cancer incidence and mortality in extended follow-up of this cohort...
  4. doi request reprint Obesity and the risk for premenopausal and postmenopausal breast cancer
    Garnet L Anderson
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, PO Box 19024, Seattle, WA 98109, USA
    Cancer Prev Res (Phila) 5:515-21. 2012
    ....
  5. ncbi request reprint Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin
    Garnet L Anderson
    WHI Clinical Coordinating Center, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N, M3 A410, P O Box 19024, Seattle, WA 98109 1024, United States
    Maturitas 55:103-15. 2006
    ..To assess the extent to which prior hormone therapy modifies the breast cancer risk found with estrogen plus progestin (E+P) in the Women's Health Initiative (WHI) randomized trial...
  6. pmc Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study
    Garnet L Anderson
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, PO Box 19024, M3 A410, Seattle, WA 98109 1024, USA
    J Natl Cancer Inst 102:26-38. 2010
    ..Except for CA125, their behavior in the prediagnostic period has not been evaluated...
  7. ncbi request reprint Monitoring and reporting of the Women's Health Initiative randomized hormone therapy trials
    Garnet L Anderson
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    Clin Trials 4:207-17. 2007
    ..The results contravened prevailing wisdom and a large body of literature regarding benefits of menopausal hormone therapy. The results and their interpretation have been the subject of considerable debate...
  8. ncbi request reprint Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial
    Garnet L Anderson
    Fred Hutchinson Cancer Research Center, Seattle, Wash 98109 1024, USA
    JAMA 291:1701-12. 2004
    ..Despite decades of use and considerable research, the role of estrogen alone in preventing chronic diseases in postmenopausal women remains uncertain...
  9. ncbi request reprint Implementation of the Women's Health Initiative study design
    Garnet L Anderson
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Ann Epidemiol 13:S5-17. 2003
  10. ncbi request reprint Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial
    Garnet L Anderson
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Wash 98109, USA
    JAMA 290:1739-48. 2003
    ..The effects of continuous combined hormone therapy on gynecologic cancers have not been investigated previously in a randomized trial setting...
  11. pmc Estrogen plus progestin therapy and breast cancer in recently postmenopausal women
    Ross L Prentice
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Am J Epidemiol 167:1207-16. 2008
    ..64 (95% confidence interval: 1.00, 2.68) over a 5-year period of use and 2.19 (95% confidence interval: 1.56, 3.08) over a 10-year period of use...
  12. pmc Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study
    Ross L Prentice
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Am J Epidemiol 167:1407-15. 2008
    ....
  13. pmc Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial
    Ross L Prentice
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, PO Box 19024, Seattle, WA 98109 1024, USA
    J Natl Cancer Inst 99:1534-43. 2007
    ..The trial protocol also listed ovarian cancer and endometrial cancer as outcomes that may be favorably affected by the intervention...
  14. pmc Influence of ovarian cancer risk status on the diagnostic performance of the serum biomarkers mesothelin, HE4, and CA125
    Chirag A Shah
    University of Washington, Seattle, WA 98195, USA
    Cancer Epidemiol Biomarkers Prev 18:1365-72. 2009
    ..To evaluate the effect of ovarian cancer risk on the performance of the serum biomarkers mesothelin, human epididymis protein 4 (HE4), and CA125...
  15. ncbi request reprint Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial
    Ross L Prentice
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Wash 98109, USA
    JAMA 295:629-42. 2006
    ..The hypothesis that a low-fat dietary pattern can reduce breast cancer risk has existed for decades but has never been tested in a controlled intervention trial...
  16. ncbi request reprint Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial
    Shirley A A Beresford
    Department of Epidemiology, University of Washington, Seattle, WA 98195 7236, USA
    JAMA 295:643-54. 2006
    ..Observational studies and polyp recurrence trials are not conclusive regarding the effects of a low-fat dietary pattern on risk of colorectal cancer, necessitating a primary prevention trial...
  17. pmc Potential role of HE4 in multimodal screening for epithelial ovarian cancer
    Nicole Urban
    Molecular Diagnostics Program, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    J Natl Cancer Inst 103:1630-4. 2011
    ..03). Serum HE4 levels were found to increase with age and smoking status, suggesting that a longitudinal algorithm might improve its performance...
  18. doi request reprint The women's health initiative: lessons learned
    Ross L Prentice
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Annu Rev Public Health 29:131-50. 2008
    ..A specimen repository and quality-controlled outcome data for a range of diseases are among the resources that support the ongoing research program. WHI clinical trial contributions and challenges are reviewed and discussed...
  19. ncbi request reprint Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease
    Ross L Prentice
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Am J Epidemiol 163:589-99. 2006
    ..An application to postmenopausal hormone treatment effects on coronary heart disease among younger women is also provided...
  20. pmc Effects of blood collection conditions on ovarian cancer serum markers
    Jason D Thorpe
    Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
    PLoS ONE 2:e1281. 2007
    ..By measuring the effects of differences in collection conditions on three different markers, we investigated the potential of these effects to bias validation studies...
  21. ncbi request reprint Comparing adaptive and non-adaptive algorithms for cancer early detection with novel biomarkers
    Alicia H Sato
    Fred Hutchinson Cancer Research Center, Seattle, WA 90109, USA
    Cancer Biomark 2:151-62. 2006
    ....
  22. pmc Efficacy of yoga for vasomotor symptoms: a randomized controlled trial
    Katherine M Newton
    From the 1Group Health Research Institute, Seattle, WA 2Departments of Obstetrics Gynecology and Epidemiology, University of Washington School of Medicine, Seattle, WA 3Data Coordinating Center, Fred Hutchinson Cancer Research Center, Seattle, WA 4School of Nursing, University of Washington, Seattle, WA 5Division of Research, Kaiser Permanente Medical Program of Northern California, Oakland, CA 6School of Nursing, Indiana University, Indianapolis, IN 7Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, IN 8Department of Obstetrics Gynecology, University of Pennsylvania, Philadelphia, PA 9Massachusetts General Hospital, Boston, MA 10Department of Medicine, VA Medical Center, Minneapolis, MN and 11Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN
    Menopause 21:339-46. 2014
    ..This study aims to determine the efficacy of yoga in alleviating vasomotor symptoms (VMS) frequency and bother...
  23. pmc Longitudinal screening algorithm that incorporates change over time in CA125 levels identifies ovarian cancer earlier than a single-threshold rule
    Charles W Drescher
    Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, M2 B230, Seattle, WA 98104, USA
    J Clin Oncol 31:387-92. 2013
    ..We demonstrated improvement in ovarian cancer early detection by using a longitudinal algorithm to monitor annual CA125 levels...
  24. pmc Multivitamin use and risk of cancer and cardiovascular disease in the Women's Health Initiative cohorts
    Marian L Neuhouser
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA 98109 1024, USA
    Arch Intern Med 169:294-304. 2009
    ..Therefore, we decided to examine associations between multivitamin use and risk of cancer, CVD, and mortality in postmenopausal women...
  25. pmc Bead-based ELISA for validation of ovarian cancer early detection markers
    Nathalie Scholler
    Translational Outcomes Research Laboratory, Fred Hutchinson Cancer Research Center, Public Health Sciences, and Harborview Medical Center, University of Washington, Seattle, Washington, USA
    Clin Cancer Res 12:2117-24. 2006
    ....
  26. pmc Hormonal factors and risks of esophageal squamous cell carcinoma and adenocarcinoma in postmenopausal women
    Clara Bodelon
    Department of Epidemiology, School of Public Health, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Cancer Prev Res (Phila) 4:840-50. 2011
    ..To provide more definitive evidence, a pooled analysis of all available studies or a much larger study would be needed...
  27. pmc Efficacy of omega-3 for vasomotor symptoms treatment: a randomized controlled trial
    Lee S Cohen
    From the 1Massachusetts General Hospital, Boston, MA 2MsFLASH Data Coordinating Center, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 3VA Medical Center, University of Minnesota, Minneapolis, MN 4School of Nursing, Indiana University, Indianapolis, IN 5Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, IN 6Group Health Research Institute, Group Health Cooperative, Seattle, WA 7Departments of Obstetrics Gynecology and Epidemiology, University of Washington School of Medicine, Seattle, WA 8Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 9Division of Research, Kaiser Permanente Medical Program of Northern California, Oakland, CA 10Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, PA and 11School of Nursing, University of Washington, Seattle, WA
    Menopause 21:347-54. 2014
    ..This study aims to determine the efficacy and tolerability of omega-3 fatty acids in reducing vasomotor symptoms (VMS) frequency and bother in perimenopausal and postmenopausal women...
  28. pmc Efficacy of exercise for menopausal symptoms: a randomized controlled trial
    Barbara Sternfeld
    From the 1Division of Research, Kaiser Permanente, Oakland, CA 2Fred Hutchison Cancer Research Center, Seattle, WA 3University of Minnesota and Minneapolis VA Health Care System, Minneapolis, MN 4Klein Buendel Inc, Denver, CO 5Division of Nutritional Sciences, Cornell University, Ithaca, NY 6School of Nursing, Indiana University, Indianapolis, IN 7Group Health Research Institute, Seattle, WA 8University of Washington, Seattle, WA 9Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, PA 10Massachusetts General Hospital, Harvard University, Boston, MA and 11National Institute for Fitness and Sport, Indianapolis, IN
    Menopause 21:330-8. 2014
    ..This study aims to determine the efficacy of exercise training for alleviating vasomotor and other menopausal symptoms...
  29. pmc Migraine history, nonsteroidal anti-inflammatory drug use, and risk of postmenopausal endometrial cancer
    Amanda I Phipps
    Public Health Sciences Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, M4 B402, Seattle, WA 98109, USA
    Horm Cancer 3:240-8. 2012
    ..Similarly, current NSAID use was not associated with endometrial cancer risk (HR = 1.01, 95% CI = 0.88-1.16), regardless of BMI. Migraine history and NSAID use do not appear to be associated with risk of endometrial cancer...
  30. ncbi request reprint Long-term exposure to air pollution and incidence of cardiovascular events in women
    Kristin A Miller
    Department of Epidemiology, University of Washington, Seattle, USA
    N Engl J Med 356:447-58. 2007
    ..We examined the association of long-term exposure to particulate matter of less than 2.5 microm in aerodynamic diameter (PM2.5) with cardiovascular events...
  31. ncbi request reprint Ethnicity and breast cancer: factors influencing differences in incidence and outcome
    Rowan T Chlebowski
    Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, 1124 W Carson St, Building J 3, Torrance, CA 90502, USA
    J Natl Cancer Inst 97:439-48. 2005
    ..The influence of breast cancer risk factors on these differences has received little attention...
  32. ncbi request reprint Coronary heart disease and stroke with aromatase inhibitor, tamoxifen, and menopausal hormone therapy use
    Rowan T Chlebowski
    Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, Torrance, CA 90502 2004, USA
    Clin Breast Cancer 6:S58-64. 2006
    ..If remaining issues are to be addressed, more rigorous CHD and stroke assessment procedures are needed in future trials evaluating AIs...
  33. ncbi request reprint The Women's Health Initiative recruitment methods and results
    Jennifer Hays
    From the WHI Clinical Center, Baylor College of Medicine, Houston, TX 77030, USA
    Ann Epidemiol 13:S18-77. 2003
  34. ncbi request reprint Statistical issues arising in the Women's Health Initiative
    Ross L Prentice
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
    Biometrics 61:899-911; discussion 911-41. 2005
    ..This final topic seems important in resolving the discrepancy between WHI clinical trial and observational study results on postmenopausal hormone therapy and cardiovascular disease...
  35. pmc Ambient fine particulate matter exposure and myocardial ischemia in the Environmental Epidemiology of Arrhythmogenesis in the Women's Health Initiative (EEAWHI) study
    Zhu Ming Zhang
    Epidemiologic Cardiology Research Center, Department of Epidemiology and Prevention, Division of Public Health Sciences, Wake Forest University School of Medicine, Winston Salem, North Carolina 27104, USA
    Environ Health Perspect 117:751-6. 2009
    ..Ambient particulate matter (PM) air pollution is associated with coronary heart disease, but the pathways underlying the association remain to be elucidated...
  36. ncbi request reprint Selecting differentially expressed genes from microarray experiments
    Margaret Sullivan Pepe
    Department of Biostatistics, University of Washington, Seattle, Washington 98195 7232, USA
    Biometrics 59:133-42. 2003
    ..Our approach leads naturally to a procedure for sample-size calculations, appropriate for exploratory studies that seek to identify differentially expressed genes...
  37. ncbi request reprint Intraindividual variability over time in plasma biomarkers of inflammation and effects of long-term storage
    Sheetal Hardikar
    Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    Cancer Causes Control 25:969-76. 2014
    ..However, more information is needed on the measurement error in these markers due to laboratory error, within-person variation over time, and long-term storage...
  38. pmc Methods for the design of vasomotor symptom trials: the menopausal strategies: finding lasting answers to symptoms and health network
    Katherine M Newton
    From the 1Group Health Research Institute, Seattle, WA 2School of Nursing, Indiana University, Indianapolis, IN 3Data Coordinating Center, Fred Hutchinson Cancer Research Center, Seattle, WA 4Division of Research, Kaiser Permanente of Northern California, Oakland, CA 5Massachusetts General Hospital Harvard Medical School, Boston, MA 6VA Medical Center University of Minnesota, Minneapolis, MN 7Departments of Obstetrics Gynecology and Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA 8Department of Obstetrics Gynecology and Department of Epidemiology, School of Public Health and Community Medicine, University of Washington, Seattle, WA 9National Institute on Aging, US National Institutes of Health, Bethesda, MD 10Center for Clinical Epidemiology and Statistics, University of Pennsylvania School of Medicine, Philadelphia, PA and 11VA Center of Excellence for Implementing Evidence Based Practice and Indiana University School of Medicine, Indianapolis, IN
    Menopause 21:45-58. 2014
    ..This report describes the Menopausal Strategies: Finding Lasting Answers to Symptoms and Health network and methodological issues addressed in designing and implementing vasomotor symptom trials...
  39. ncbi request reprint Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial
    Jacques E Rossouw
    Division of Women s Health Initiative, National Heart, Lung, and Blood Institute, 6705 Rockledge Dr, One Rockledge Ctr, Suite 300, Bethesda, MD 20817
    JAMA 288:321-33. 2002
    ..Despite decades of accumulated observational evidence, the balance of risks and benefits for hormone use in healthy postmenopausal women remains uncertain...
  40. ncbi request reprint Predicting risk of breast cancer in postmenopausal women by hormone receptor status
    Rowan T Chlebowski
    Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, 1124 West Carson Street, Torrance, CA 90502, USA
    J Natl Cancer Inst 99:1695-705. 2007
    ..We evaluated and attempted to improve the performance of the Breast Cancer Risk Assessment Tool (i.e., the Gail model) for estimating invasive breast cancer risk by receptor status in postmenopausal women...
  41. ncbi request reprint Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy
    Marcia L Stefanick
    Stanford Prevention Research Center, Department of Medicine, Stanford University, Stanford, Calif 94305, USA
    JAMA 295:1647-57. 2006
    ..Preliminary results suggesting possible reduction in breast cancers warranted more detailed analysis...
  42. ncbi request reprint Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial
    Barbara V Howard
    MedStar Research Institute Howard University, Washington, DC, USA
    JAMA 295:655-66. 2006
    ..Multiple epidemiologic studies and some trials have linked diet with cardiovascular disease (CVD) prevention, but long-term intervention data are needed...
  43. doi request reprint Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women
    Marc J Gunter
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York 10461, USA
    Cancer Res 68:329-37. 2008
    ....
  44. doi request reprint Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin
    Gerardo Heiss
    University of North Carolina, School of Public Health, Department of Epidemiology, Chapel Hill, NC 27514 3628, USA
    JAMA 299:1036-45. 2008
    ..The Women's Health Initiative (WHI) trial of estrogen plus progestin vs placebo was stopped early, after a mean 5.6 years of follow-up, because the overall health risks of hormone therapy exceeded its benefits...
  45. ncbi request reprint Calcium plus vitamin D supplementation and the risk of colorectal cancer
    Jean Wactawski-Wende
    Department of Social and Preventive Medicine, University at Buffalo, 270 Farber Hall, Buffalo, NY 14214, USA
    N Engl J Med 354:684-96. 2006
    ..However, randomized-trial evidence that calcium with vitamin D supplementation is beneficial in the primary prevention of colorectal cancer is lacking...
  46. ncbi request reprint Progestins and recurrence in breast cancer survivors
    Rowan T Chlebowski
    J Natl Cancer Inst 97:471-2. 2005
  47. ncbi request reprint Projecting individualized absolute invasive breast cancer risk in African American women
    Mitchell H Gail
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Executive Plaza South Rm 8032, Bethesda, MD 20892 7244, USA
    J Natl Cancer Inst 99:1782-92. 2007
    ..We developed a model for projecting absolute risk of invasive breast cancer in African American women and compared its projections with those from the Breast Cancer Risk Assessment Tool...
  48. ncbi request reprint Calcium plus vitamin D supplementation and the risk of fractures
    Rebecca D Jackson
    Division of Endocrinology, Ohio State University, 485 McCampbell, 1581 Dodd Dr, Columbus, OH 43210, USA
    N Engl J Med 354:669-83. 2006
    ..The efficacy of calcium with vitamin D supplementation for preventing hip and other fractures in healthy postmenopausal women remains equivocal...
  49. pmc Use of yeast-secreted in vivo biotinylated recombinant antibodies (Biobodies) in bead-based ELISA
    Nathalie Scholler
    School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 96104 6069, USA
    Clin Cancer Res 14:2647-55. 2008
    ..Mouse monoclonal antibodies (mAb) and polyclonal antibodies (pAb) are commonly used, but because their production is lengthy and costly, recombinant antibodies are emerging as an attractive alternative...
  50. ncbi request reprint Concerns about published data from the estrogen-progestin (HT) arm of the WHI
    Margery Gass
    Am J Obstet Gynecol 192:333; author reply 334. 2005